Innovative Diagnostic Tool EpiFinder is developing proprietary software designed to assist neurologists in diagnosing epilepsy more accurately and efficiently at the point of care, representing a valuable solution for hospitals aiming to enhance diagnostic precision.
Recognition & Awards The company has received multiple industry awards, including Silver Stevie® Awards in 2018, which enhance its credibility and visibility in the healthcare and tech startup sectors—offering leverage for marketing and partnership opportunities.
Funding & Growth With nearly $1 million in investments and grants from notable organizations like the Flinn Foundation and Arizona State University Foundation, EpiFinder demonstrates strong financial backing and growth potential, making it attractive to potential partners and investors.
Market Positioning Operating in the competitive epilepsy diagnosis space with a focus on healthcare providers and hospitals, EpiFinder is positioned to capture market share by providing innovative technology solutions for neurological diagnostics.
Expansion & Engagement The launch of a patient portal app and the company’s engagement in university internship programs suggest ongoing product development and workforce development, opening avenues for strategic partnerships with academic institutions and healthcare organizations seeking digital health expansions.